We know that recent actions by the federal government are having a significant impact on many Association of Clinical Research Professionals (ACRP) members as well as others involved in the vital global clinical research enterprise.
ACRP’s role is to serve as a strong voice for the highest standards in the conduct of clinical research. For nearly 50 years, the clinical research enterprise—including federal agencies that fund and safeguard it—has relied on ACRP’s workforce training and accredited certification to prepare and support the professionals at the heart of the multibillion-dollar clinical research and drug development industries. These professionals provide the essential connection, protection, and hope to the people and patients around the world who choose to participate in the drug discovery process that results in breakthrough medical therapies.
Today, ACRP reaffirms our steadfast dedication to supporting you—our association of more than 17,000 members, 11,000 credentialed professionals, and 40 chapters who thrive on collaboration and community, and who champion the safe, quality, and ethical conduct of clinical research.
We reaffirm our mission and vision: to promote excellence in clinical research and to ensure that clinical research is performed ethically, responsibly, and professionally everywhere in the world.
We reiterate our commitment to building a diverse clinical research workforce, because it contributes directly to a more representative population of participants in research and, therefore, allows everyone to share in the benefits of clinical research and in improved health outcomes.
As a leader correctly observed during the 2024 ACRP Annual Conference, every day clinical research professionals drive innovation because that’s what clinical research is. Never lose sight of this contribution you make.
We are honored to serve you, and we remain committed to your learning, leadership, and livelihood.
